Edesa Biotech(EDSA)
ON - MarkhamBiotechnology
Focus: Edesa Biotech is a public Canadian biotech company focused on developing topical and suppository formulations for neurology and inflammatory conditions. As a pre-revenue biotech with a small cash position, it operates at early clinical stage with limited market scale.
Profile data last refreshed 15h ago · AI intelligence enriched 2w ago
Funding Stage
PUBLIC
Open Jobs
0
About Edesa Biotech
AI assessmentNot HiringNo open roles listed right now. Follow Edesa Biotech to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
3/9 — Basic
Company HealthSolid
Pipeline
Early-stage
6 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Cohort C: bevacizumab
Acute Respiratory Distress Syndrome (ARDS)Cohort A: vilobelimab
Acute Respiratory Distress Syndrome (ARDS)Help build intelligence for Edesa Biotech
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.